Is Guided Antiplatelet Therapy Ready for Prime Time? – Davide Capodanno

Bridgining Antithrombotic Strategies in Patients with Coronary Stent Requiring Surgery – Giuseppe Musumeci

Vascular dose of rivaroxaban: from evidence to practice – Marco Ferlini

<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

Redazione ATBV

Comments are closed.